Clinical trial

Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With…

NCT00344968 · Alimera Sciences, Industry · Completed

Key facts

NCT number NCT00344968
Title Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema
Official title A Randomized, Double-Masked, Parallel Group, Multi-center, Dose-Finding Comparison of the Safety and Efficacy of ASI-001A 0.5 μg/Day and ASI-001B 0.2 μg/Day Fluocinolone Acetonide Intravitreal Inserts to Sham Injection in Subjects With Diabetic Macular Edema
Acronym FAME
Lead sponsor Alimera Sciences, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Diabetic Macular Edema
Intervention type Drug, Procedure
Interventions fluocinolone acetonide, Fluocinolone Acetonide, Standard of care laser photocoagulation
Enrollment 956
Start date Sep 1, 2007
Primary completion Dec 1, 2009
Completion Dec 1, 2010
First posted Jun 27, 2006
Last update posted May 7, 2014
Countries United States

At a glance

  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies